The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Regulatory News (NCYT)

Share Price Information for Novacyt (NCYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.40 (6.769%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 67.20
NCYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

5 Mar 2020 17:09

RNS Number : 2032F
Novacyt S.A.
05 March 2020
 

Notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Novacyt S.A

LEI: 213800BWAC2BF295EG28

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligation

Name

HARBERT EUROPEAN GROWTH CAPITAL FUND II, SCSp

City and country of registered office (if applicable)

Luxembourg

Grand Duchy of Luxembourg

4. Full name of shareholder(s) (if different from 3)

Name

n/a

City and country of registered office (if applicable)

n/a

5. Date on which the threshold was crossed or reached :

4th March 2020

6. Date on which issuer notified (DD/MM/YYYY):

5th March 2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

1.88%

 

1.88%

 67 673 567

Position of previous notification (if

applicable)

8.89%

 

8.89%

N/A

 

 

 

 

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

 

1,270,624

 

1.88%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

1,270,624

1.88%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

n/a

The number and % of voting rights held

n/a

The date until which the voting rights will be held

n/a

 

11. Additional information

 

 

 

 

 

 

 

Place of completion

London, United Kingdom

Date of completion

4th March 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUVRBRRUUORAR
Date   Source Headline
19th Jun 20197:00 amRNSConversion of Loan Notes
14th Jun 20192:45 pmRNSConversion of Loan Notes
3rd Jun 20192:00 pmRNSLiquidity Agreement and Total Voting Rights
24th May 20197:00 amRNSPublication of Annual Report and Notice of AGM
17th May 20194:35 pmRNSConversion of Loan Notes
15th May 20195:30 pmRNSConversion of Loan Notes
13th May 20197:00 amRNSLaunch of Next-Generation qPCR Instrument
3rd May 20196:23 pmRNSConversion of Loan Notes
3rd May 20197:00 amRNSChange of Adviser
1st May 20195:30 pmRNSLiquidity Agreement
30th Apr 20197:00 amRNSFull Year 2018 Results
25th Apr 20197:00 amRNSUpdate on Notice of Full Year Results
23rd Apr 20197:00 amRNSConvertible Bond Facility
8th Apr 20197:00 amRNSExpanded Development Partnership with Immunexpress
1st Apr 20192:30 pmRNSLiquidity Agreement and Total Voting Rights
4th Mar 20197:00 amRNSLiquidity Agreement and Total Voting Rights
26th Feb 20197:00 amRNSFunding Update
1st Feb 20192:00 pmRNSLiquidity Agreement and Total Voting Rights
22nd Jan 20197:00 amRNSRevenues Full Year 2018
2nd Jan 201912:30 pmRNSLiquidity Agreement and Total Voting Rights
24th Dec 20187:00 amRNSTrading Update
21st Dec 20187:00 amRNSNovacyt launches two new molecular diagnostic kits
11th Dec 20187:00 amRNSUpdate on Strategic Review
6th Dec 20187:00 amRNSCompletion of q16 molecular diagnostics order
3rd Dec 20181:00 pmRNSLiquidity Agreement and Total Voting Rights
30th Nov 201812:06 pmRNSReplacement: Unsecured Debt Facility
27th Nov 20187:00 amRNS$3.0M supply agreement with Genesis Diagnostics
1st Nov 20185:45 pmRNSLiquidity Agreement
1st Oct 201810:51 amRNSLiquidity Agreement and Total Voting Rights
26th Sep 20187:00 amRNSNovacyt Half Year 2018 Results
13th Sep 20187:00 amRNSNovacyt Partners with Applied Microarrays
3rd Sep 201811:15 amRNSLiquidity Agreement and Total Voting Rights
2nd Aug 201810:30 amRNSLiquidity Agreement and Total Voting Rights
2nd Aug 20187:00 amRNSHalf Year Revenue Update
26th Jul 20187:00 amRNSRevenue update to be announced on 2 August 2018
2nd Jul 201811:45 amRNSLiquidity Agreement Update and Total Voting Rights
28th Jun 20187:00 amRNSAcquisition of ID Business from Omega Diagnostics
12th Jun 201811:45 amRNSReplacement - Results of Annual General Meeting
12th Jun 20187:00 amRNSResults of Annual General Meeting
5th Jun 20187:00 amRNSLaunch of New Product in Infectious Mononucleosis
1st Jun 20183:30 pmRNSLiquidity Agreement and Total Voting Rights
30th May 20186:30 pmRNSNew Unsecured Debt Facility
23rd May 20182:51 pmRNSPublication of Annual Report and Notice of AGM
1st May 20184:30 pmRNSLiquidity Agreement Update and Total Voting Rights
26th Apr 20187:00 amRNSNovacyt Full Year 2017 Results
3rd Apr 20181:30 pmRNSLiquidity Agreement Update and Total Voting Rights
22nd Mar 20187:00 amRNSSigning of Assay Development Contract with GenePOC
1st Mar 20182:59 pmRNSLiquidity Agreement Update and Total Voting Rights
1st Feb 20183:15 pmRNSLiquidity Agreement Update and Total Voting Rights
26th Jan 20189:32 amRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.